Výsledky vyhledávání - "van Leeuwen JH"

Akademický článek

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.

Autor: Aronson SL; Department of Gynecologic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Lopez-Yurda M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Koole SN; Department of Gynecologic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Schagen van Leeuwen JH; Department of Obstetrics and Gynecology, Sint Antonius Hospital, Nieuwegein, Netherlands., Schreuder HWR; Department of Gynecologic Oncology, UMC Utrecht Cancer Center, Utrecht, Netherlands., Hermans RHM; Department of Gynecology and Obstetrics, Catharina Hospital, Eindhoven, Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands; Department of Epidemiology, GROW-School for Oncology Reproduction, Maastricht University, Maastricht, Netherlands., van Gent MDJM; Department of Obstetrics and Gynecology, Amsterdam University Medical Center, Amsterdam, Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, Netherlands., Arts HJG; Department of Gynecologic Oncology, University Medical Center Groningen, Groningen, Netherlands., van Ham MAPC; Department of Gynecologic Oncology, Radboud University Medical Centre, Nijmegen, Netherlands., van Dam PA; Department of Gynecologic Oncology, University Hospital Antwerp, Antwerp, Belgium., Vuylsteke P; Department of Medical Oncology, UCL Louvain, CHU Namur Sainte-Elisabeth, Namur, Belgium; Department of Internal Medicine, University of Botswana, Gaborone, Botswana., Aalbers AGJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Verwaal VJ; Department of Surgery, Skåne University Hospital, Malmö, Sweden., Van de Vijver KK; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Aaronson NK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Driel WJ; Department of Gynecologic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, Netherlands. Electronic address: w.v.driel@nki.nl.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Oct; Vol. 24 (10), pp. 1109-1118. Date of Electronic Publication: 2023 Sep 11.

Zobrazit plný text záznamu

Akademický článek

Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.

Autor: Koole SN; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hauke J; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Nederlof P; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Richters LK; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Krebsbach G; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Sikorska K; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Alkemade M; Core Facility of Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Core Facility of Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schagen van Leeuwen JH; Department of Obstetrics & Gynecology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Schreuder HWR; Department of Gynecological Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Hermans RHM; Department of Gynecology and Obstetrics, Catharina Hospital, Eindhoven, The Netherlands., de Hingh IHJT; Department of Surgical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Mom CH; Department of Obstetrics and Gynecology, Amsterdam University Medical Center, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Arts HJG; Department of Gynecological Oncology, University Medical Center Groningen, Groningen, The Netherlands., van Ham M; Department of Gynecological Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van Dam P; Department of Gynecologic Oncology, University Hospital Antwerp, Antwerp, Belgium., Vuylsteke P; Department of Medical Oncology, UCL Louvain, CHU Namur Sainte-Elisabeth, Namur, Belgium.; University of Botswana, Gaborone, Botswana., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van de Vijver KK; Department of Pathology, University Hospital Ghent, Ghent, Belgium., Hahnen E; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., van Driel WJ; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Schmutzler R; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2022 Oct 15; Vol. 151 (8), pp. 1394-1404. Date of Electronic Publication: 2022 Jun 04.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání